transforaminal epidural injection.
PreclinicalSmall molecule
transforaminal epidural injection. is one of 9 small molecule programs targeting Sciatica. It is currently in Preclinical.
1
Indications
3
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
9 competitors in Sciatica
#DrugCompanyPhaseTrials
1Medrol
PfizerApproved
Aleve
Jazz PharmaceuticalsApproved
Decadron
AAspen Global Incorporated
Approved
Oruvail
WWyeth-Lederle Vaccines
Approved
Advil
KKenvue Brands
Approved
Demerol
QQuagen
Approved
Medrol
PfizerPreclinical
Xylocaine
MMEDRx USA, Inc.
Preclinical
transforaminal epidural injection.
EEduard Verheijen
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Steroid Injection1 trial
Impact of Transforaminal Epidural Steroid Injection in Lumbar Disc Prolpse on Micro RNA-155 Serum Level
Completed·—·Phase 4·NCT05626283·88 enrolled
Treatment1 trial
Effect of Pulsed Mode Radiofrequency as a Treatment of Lumbar Disc Related Radicular Pain on Tumor Necrotic Factor α Level
Completed·—·Phase 1·NCT05288920·80 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- EEduard Verheijen